A novel PPARα/γ agonist, propane-2-sulfonic acid octadec-9-enyl-amide, ameliorates insulin resistance and gluconeogenesis in vivo and vitro. [electronic resource]
Producer: 20180910Description: 1-8 p. digitalISSN:- 1879-0712
- Animals
- Diabetes Mellitus, Experimental -- drug therapy
- Diabetes Mellitus, Type 2 -- drug therapy
- Diet, High-Fat -- adverse effects
- Dyslipidemias -- drug therapy
- Gluconeogenesis -- drug effects
- Hep G2 Cells
- Humans
- Insulin Resistance
- Lipid Metabolism -- drug effects
- Male
- Mice
- Mice, Inbred C57BL
- PPAR alpha -- agonists
- PPAR gamma -- agonists
- Streptozocin -- toxicity
- Sulfonic Acids -- pharmacology
- Transcriptional Activation
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.